![Jeffrey Nelson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Nelson
Operationeel Directeur bij
MILESTONE PHARMACEUTICALS INC.
Vermogen: 55 331 $ op 31-07-2026
Profiel
Jeffrey Nelson is Chief Operating Officer at Milestone Pharmaceuticals, Inc. since 2020.
Formerly, Mr. Nelson was Vice President-Program Management at Oncotelic Therapeutics, Inc. from 2015 to 2017 and Head-Clinical Operations at Axsome Therapeutics, Inc. from 2014 to 2015.
Mr. Nelson completed an undergraduate degree at Brandeis University in 2003.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-02-2026 | 49.848 ( 0,04% ) | 55 331 $ | 31-07-2026 |
Actieve functies van Jeffrey Nelson
| Bedrijven | Functie | Begin |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Operationeel Directeur | 01-06-2020 |
Eerdere bekende functies van Jeffrey Nelson
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2017 |
| AXSOME THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Opleiding van Jeffrey Nelson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
72
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
